A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated Classic Kaposi sarcoma (CKS).

Alona Zer,O. Icht,Lilach Joseph,Dana Avram,O. Jacobi,Eyal Fenig,Sivan Shamai,Ronnie Shapira-Frommer,Hanna Bernstine,Rony Weitzen,Gil Bar-Sela,Salomon M. Stemmer,Michal Lotem

A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated Classic Kaposi sarcoma (CKS).

2019

Alona Zer
O. Icht
Lilach Joseph
Dana Avram
O. Jacobi
Eyal Fenig
Sivan Shamai
Ronnie Shapira-Frommer
Hanna Bernstine
Rony Weitzen
Gil Bar-Sela
Salomon M. Stemmer
Michal Lotem

11064Background: CKS is an angioproliferative mesenchymal neoplasm causatively associated with human herpes virus 8 infection. Though recombinant IFNa is approved for treatment of AIDS-related KS, ...

Keywords:

Virus
Medicine
Ipilimumab
Single Arm Study
Classic Kaposi Sarcoma
Nivolumab
Pathology
Mesenchymal Neoplasm
Cancer research
human herpes virus
Recombinant DNA
previously treated

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations